Sarilumab: A New IL-6 Receptor Blocker for Rheumatoid Arthritis

Prescriber - United Kingdom
doi 10.1002/psb.1628
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Sarilumab for the Treatment of Rheumatoid Arthritis

Immunotherapy
OncologyAllergyImmunology
2016English

Inhibitor of Biological Effects of Interleukin-6 Sarilumab in Treatment of Rheumatoid Arthritis

Medical Council
2019English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

AB0424 Il-6 Receptor Blockade Induced a Different Immune Response in Rheumatoid Arthritis Patients With and Without Remission

2018English

Pms84 - Comparison of Hta Assessments of Sarilumab in Different Subpopulations for Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Proinflammatory Role for IL-18 in Rheumatoid Arthritis

Journal of Clinical Investigation
Medicine
1999English

IL-6; IL-6 Receptor (CD126)

Science-Business eXchange
2009English

Disease–Drug Interaction of Sarilumab and Simvastatin in Patients With Rheumatoid Arthritis

Clinical Pharmacokinetics
Pharmacology
2016English

Profile of Sarilumab and Its Potential in the Treatment of Rheumatoid Arthritis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy